New ACC research: proteome subtypes and two trials to watch.
Here is what is new for adrenal cortex carcinoma patients and caregivers.
๐งฌ Proteome-based tumor subtypes
A paper analyzed 83 pediatric adrenocortical tumors using mass spectrometry (a method to measure proteins).
It found four distinct protein patterns that predict survival and treatment vulnerabilities.
This helps explain why some tumors behave differently despite looking similar under a microscope.
๐ Carfilzomib liver pump trial
A Phase 1 trial run by the National Cancer Institute tests carfilzomib (a drug for other cancers) via a liver pump.
It is for patients with liver metastases from adrenal, colon, or bile duct cancer.
The trial is not yet recruiting, with an expected start date of October 20, 2026.
๐ DS9051b international trial
A Phase 1 study by Daiichi Sankyo is recruiting for advanced adrenocortical carcinoma.
It enrolls at Columbia University, Brown University, and other US centers, plus sites in France and the UK.
This first-in-human study aims to check safety and early signs of effectiveness for DS9051b.
#AdrenocorticalCarcinoma #CancerResearch #ACC #ClinicalTrials
AI-generated; for informational purposes only, not medical advice